Update on Marketing Authorization Application for Lecanemab in the European Union
Update on Marketing Authorization Application for Lecanemab in the European Union
January 11, 2024
Eisai has announced an update on the regulatory review of lecanemab by the European Medicines Agency. Additional details can be found in a news release available on Eisai’s website.
